ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Barcelona, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Obesity
Foot Ulcer
Overweight

Diabetes trials near Barcelona, CT, ESP:

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Barcelona, Spain and 59 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Barcelona, Spain and 78 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Barcelona, Spain and 178 other locations

This study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, co...

Enrolling
Diabetes Mellitus, Type 2
Diabetic Peripheral Neuropathy
Drug: CagriSema (Cagrilintide B and Semaglutide I)
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Phase 2

Novo Nordisk
Novo Nordisk

Barcelona, Spain and 47 other locations

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Enrolling
Diabetes Mellitus, Type 2
Drug: AZD5004
Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca
AstraZeneca

Barcelona, Spain and 119 other locations

The goal of this study is to determine if treatment with TCD601 improves beta-cell function in adults recently diagnosed with type 1 diabetes...

Active, not recruiting
Diabetes Mellitus, Type 1
Other: Placebo
Biological: TCD601

Phase 2

ITBMed

Barcelona, Spain and 26 other locations

medical purpose population, i.e., in individuals with unknown diabetes risk. Additionally, this investigation will serve as a pivotal perfor...

Active, not recruiting
Pre-diabetes
Undiagnosed Diseases
Device: Near-infrared (NIR)
Glyconics

Barcelona, Spain

help lower the blood sugar and body weight in people with type 2 diabetes. NNC0487-0111 is a new medicine which cannot be prescribed by doct...

Enrolling
Type 2 Diabetes (T2D)
Drug: Placebo (NNC0487-0111 oral)
Drug: NNC0487-0111 oral

Phase 2

Novo Nordisk
Novo Nordisk

Barcelona, Spain and 103 other locations

The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or ov...

Not yet enrolling
Type 1 Diabetes
Overweight
Drug: Tirzepatide
Drug: Placebo

Phase 3

Lilly
Lilly

Barcelona, Spain and 147 other locations

The study medicine will be investigated in participants with type 2 diabetes. Participants will either get insulin icodec or insulin glargin...

Active, not recruiting
Diabetes, Type 2
Drug: Insulin glargine
Drug: Insulin icodec

Phase 3

Novo Nordisk
Novo Nordisk

Barcelona, Spain and 69 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems